Toxicological Research & Testing Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 04-12-2024
- Paid Up Capital ₹ 0.40 M
as on 04-12-2024
- Company Age 17 Year, 18 Days
- Last Filing with ROC 31 Mar 2024
- Revenue -10.47%
(FY 2022)
- Profit 13.98%
(FY 2022)
- Ebitda 9.59%
(FY 2022)
- Net Worth 16.00%
(FY 2022)
- Total Assets 50.31%
(FY 2022)
About Toxicological Research & Testing Laboratories
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.40 M, as per Ministry of Corporate Affairs (MCA) records.
Vipul Shah and Gurunath Pandit serve as directors at the Company.
- CIN/LLPIN
U73100MH2007PTC177045
- Company No.
177045
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Dec 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationNavi Mumbai, Maharashtra
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Toxicological Research & Testing Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vipul Shah  | Director | 24-Dec-2007 | Current |
| Gurunath Pandit | Director | 24-Dec-2007 | Current |
Financial Performance of Toxicological Research & Testing Laboratories.
Toxicological Research & Testing Laboratories Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 10.47% decrease. The company also saw a substantial improvement in profitability, with a 13.98% increase in profit. The company's net worth Soared by an impressive increase of 16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Toxicological Research & Testing Laboratories?
In 2021, Toxicological Research & Testing Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anazeal Analyticals & Research Private LimitedActive 22 years 7 monthsVipul Shah and Gurunath Pandit are mutual person
Osil Estate Private LimitedActive 19 years 5 monthsVipul Shah and Gurunath Pandit are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Toxicological Research & Testing Laboratories?
Unlock and access historical data on people associated with Toxicological Research & Testing Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Toxicological Research & Testing Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Toxicological Research & Testing Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
